Chemed Corporation Reports Strong Q1 2026 Earnings with Growth in VITAS and Roto-Rooter
Chemed Corporation's Q1 2026 earnings call highlighted strong performance from its VITAS hospice division, which exceeded expectations and added $32.5 million to its Medicare Cap cushion. Roto-Rooter saw core residential service revenue growth for the first time since late 2022, though it faced challenges from Google's algorithm changes and weather disruptions. The company also announced strategic acquisitions and updated its 2026 guidance.
Topics: Earnings Call Franchise Acquisitions Q1 2026 Results Roto-Rooter Growth Strategic Outlook VITAS Performance